首页> 外国专利> HYDRONAPHTHALENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM, USE THEREOF, AND THEIR PREPARATION BY A RHODIUM CATALYZED RING OPENING REACTION IN THE PRESENCE OF PHOSPHINE LIGAND

HYDRONAPHTHALENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM, USE THEREOF, AND THEIR PREPARATION BY A RHODIUM CATALYZED RING OPENING REACTION IN THE PRESENCE OF PHOSPHINE LIGAND

机译:萘酚化合物,包含它们的药物组合物,使用它们以及在磷配位基存在下通过铑催化的开环反应制备它们

摘要

The present invention is directed to a procedure for making an enantiomerically enriched compound containing a hydronaphthalene ring structure. The process involves reacting oxabenzonorbornadienes with nucleophiles using rhodium as a catalyst and in the presence of a phosphine ligand. The compounds synthesized may be used in pharmaceutical preparations for the treatment of a variety of diseases and conditions.
机译:本发明涉及制备含有对苯二酚环结构的对映体富集化合物的方法。该方法包括使用铑作为催化剂并在膦配体存在下,使氧杂苯并降冰片二烯与亲核试剂反应。合成的化合物可以用于治疗各种疾病和病症的药物制剂中。

著录项

  • 公开/公告号IL149368B

    专利类型

  • 公开/公告日2009-09-01

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;KEITH FAGNOU;MARK LAUTENS;

    申请/专利号IL149368

  • 发明设计人 MARK LAUTENS;KEITH FAGNOU;

    申请日2002-04-25

  • 分类号C07D295/08;A61K31/055;A61K31/085;A61K31/09;A61K31/136;A61K31/18;A61K31/222;A61K31/225;A61K31/235;A61K31/27;A61K31/277;A61K31/36;A61K31/40;A61K31/4035;A61K31/404;A61K31/4453;A61K31/47;A61K31/472;A61K31/4725;A61P25/16;A61P29/00;A61P31/04;A61P31/12;A61P31/18;A61P35/00;A61P37/02;A61P43/00;C07B61/00;C07C27/00;C07C41/01;C07C41/03;C07C43/196;C07C43/23;C07C43/253;C07C43/295;C07C45/71;C07C49/84;C07C67/24;C07C69/013;C07C69/16;C07C69/732;C07C205/38;C07C215/44;C07C215/86;C07C217/52;C07C219/00;C07C255/54;C07C271/24;C07C271/28;C07C311/20;C07C311/21;C07D209/08;C07D209/48;C07D215/06;C07D217/04;C07D295/096;C07D295/12;C07D295/135;C07D317/70;C07D493/08;C07D493/18;C07F7/08;C07F7/18;

  • 国家 IL

  • 入库时间 2022-08-21 19:27:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号